• Human Genome Sciences, Inc. (HGSI) Sets Deadline for Buyout Offers More...

• Viscient Acquires Environmental Sciences Group from Covance Inc. (CVD) More...

• Pfizer Inc. (PFE) Inks Pact With Harvard University to Spark Innovation for New Drugs More...

• Plasticell and Veritas Corporation Announce an Exclusive Distribution Agreement in Japan More...

• Merck & Co., Inc. (MRK) Release: New Partnership With U.S. and Norwegian Governments and the Private Sector Formed to Save the Lives of Mothers and Their Newborn Children More...

• The Scripps Research Institute Release: Announces Five-Year Research Collaboration with Bristol-Myers Squibb Company (BMY) More...

• ViaCyte, Inc. (Formerly Known as Novocell, Inc.)Appoints Dr. Paul Laikind Chief Executive Officer More...

• bioRASI Names David Judson Vice President, Chief Compliance Officer More...

• China Nuokang Bio-Pharmaceutical Inc. (NKBP) Announces Change in CFO More...

• Cellerant Therapeutics, Inc. Appoints Gisela Schwab, M.D., to Its Board of Directors and Names Lowell Sears as Chairman of the Board More...

• Dr. Lex Van der Ploeg Has Been Elected to the Neurotez, Inc. Board of Directors More...

• Helix Biopharma (CC:HBP) Announces Q3 2012 Results and Actions Taken by Its New Board More...

• Breckenridge Pharmaceutical, Inc., Alembic Settles Patent Dispute With Novartis AG (NVS) Over Copycat Drug More...

• Feds Arrest Canadian Online Pharmacy Pioneer for Selling Fake Drugs More...

• Ameritox, Ltd. Release: Court Preliminarily Deems Millennium Laboratories' Press Release "Misleading" More...

• Pfizer Inc. (PFE) Pill Targets Dz That Kills From the Feet Up More...

• Johnson & Johnson (JNJ)'s) Janssen-Cilag International NV (JNJ) Submits Additional Marketing Application for ZYTIGA More...

• FDA Approves GlaxoSmithKline (GSK)'s Meningitis Vaccine for Children More...

• MEDA: Edluar Approved in Europe More...

• CytoPharm and Amarillo Biosciences (AMAR) Announce Positive HCV Study Results: Oral Interferon Found to Reverse Thrombocytopenia; Reduced Relapse Rate Seen in Patients With Mild Fibrosis More...

• Pharming Group (PHGUF.PK) Updates on Study 1310 and Shares in Issue More...

• Glycotope Moves PankoMab™ Towards Phase-II Clinical Development More...

• Civitas Therapeutics Initiates Phase 2a Clinical Study of CVT-301, an Inhaled L-dopa for Parkinson's Disease More...

• Generex Biotechnology Corporation (GNBT) Announces Publication of Abstract at American Society of Clinical Oncology 2012 Showing Potential of Antigen Express, Inc. (GNBT) AE37 Immunotherapeutic Cancer Vaccine Technology in Prostate Cancer More...

• Mom's Smoking Tied to Dangerous Gut Illness in Preemies, University of Louisville Study More...

• Soft Drink Consumption Not Major Risk Factor for Obesity, Applied Physiology, Nutrition, and Metabolism Reveals More...

• TeraDiscoveries Announces the Design of Six New Drugs In-Silico as Part of Strategic Relationship More...

• Data from Sequenta's LymphoSIGHTTM Platform for the Detection of Minimal Residual Disease Presented at the European Hematology Association Meeting More...

• European Academy of Allergology and Clinical Immunology Release: Eczema in Babies Due to Stress in Pregnancy More...

• Bion Announces Approval of New U.S. Patent More...

• National Institute for Clinical Excellence (NICE) Rejects Use of Roche (RHHBY)'s Melanoma Drug Zelboraf More...